187
Participants
Start Date
November 6, 2019
Primary Completion Date
October 28, 2021
Study Completion Date
October 28, 2021
Trofinetide
Trofinetide solution administered based on the subject's weight at Baseline, twice daily for 12 weeks
Placebo
Trofinetide placebo solution administered based on the subject's weight at Baseline, twice daily for 12 weeks
Montefiore Medical Center, Children's Hospital at Montefiore, The Bronx
Children's Hospital of Philadelphia, Philadelphia
Kennedy Krieger Institute - Clinical Trials Unit, Baltimore
The University of North Carolina at Chapel Hill, Chapel Hill
Greenwood Genetic Center, Greenwood
Emory Genetics Clinical Trial Center, Atlanta
Children Medical Services, Tampa
University of Alabama at Birmingham, Birmingham
Vanderbilt University Medical Center, Nashville
Cleveland Clinic, Cleveland
Cincinnati Children's Hospital Medical Center, Cincinnati
Gillette Children's Specialty Healthcare, Saint Paul
Rush University Children's Hospital, Chicago
Washington University School of Medicine, St Louis
Texas Children's Hospital, Houston
Children's Hospital Colorado, Aurora
Translational Gemomics Research Institute (TGen), Phoenix
University of California, San Diego, La Jolla
UC Davis MIND Institute, Sacramento
Seattle Children's, Seattle
Boston Children's Hospital Harvard Medical School, Boston
Lead Sponsor
ACADIA Pharmaceuticals Inc.
INDUSTRY